Amalgamated Bank Has $3.50 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Amalgamated Bank lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 38,089 shares of the medical device company’s stock after selling 820 shares during the quarter. Amalgamated Bank’s holdings in Cooper Companies were worth $3,502,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Fulton Bank N.A. increased its stake in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Mather Group LLC. grew its holdings in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB grew its holdings in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after purchasing an additional 136 shares during the period. Greenleaf Trust increased its stake in Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of Cooper Companies by 22.5% during the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after purchasing an additional 142 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $90.38 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market cap of $18.04 billion, a PE ratio of 46.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The stock’s fifty day simple moving average is $92.64 and its two-hundred day simple moving average is $99.48. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the company earned $0.87 earnings per share. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on the company. Morgan Stanley reduced their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company upped their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup cut their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.